Elevance Health, Inc. Quarterly Other Long-term Investments in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term investments classified as other.
Summary
Elevance Health, Inc. quarterly Other Long-term Investments history and growth rate from Q1 2010 to Q2 2024.
  • Elevance Health, Inc. Other Long-term Investments for the quarter ending June 30, 2024 was $6.81B, a 13.6% increase year-over-year.
Other Long-term Investments, Quarterly (USD)
Other Long-term Investments, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $6.81B +$817M +13.6% Jun 30, 2024 10-Q 2024-07-17
Q1 2024 $6.71B +$742M +12.4% Mar 31, 2024 10-Q 2024-04-18
Q4 2023 $6.11B +$422M +7.42% Dec 31, 2023 10-Q 2024-07-17
Q3 2023 $6.12B +$602M +10.9% Sep 30, 2023 10-Q 2023-10-18
Q2 2023 $5.99B +$595M +11% Jun 30, 2023 10-Q/A 2023-09-29
Q1 2023 $5.97B +$606M +11.3% Mar 31, 2023 10-Q 2023-04-19
Q4 2022 $5.69B +$460M +8.8% Dec 31, 2022 10-K 2024-02-21
Q3 2022 $5.52B +$557M +11.2% Sep 30, 2022 10-Q 2022-10-19
Q2 2022 $5.4B +$481M +9.78% Jun 30, 2022 10-Q 2022-07-20
Q1 2022 $5.37B +$891M +19.9% Mar 31, 2022 10-Q 2022-04-20
Q4 2021 $5.23B +$940M +21.9% Dec 31, 2021 10-Q 2023-10-18
Q3 2021 $4.96B +$789M +18.9% Sep 30, 2021 10-Q 2021-10-20
Q2 2021 $4.92B +$820M +20% Jun 30, 2021 10-Q 2021-07-21
Q1 2021 $4.47B +$293M +7.01% Mar 31, 2021 10-Q 2021-04-21
Q4 2020 $4.29B +$27M +0.63% Dec 31, 2020 10-K 2022-02-16
Q3 2020 $4.17B +$256M +6.54% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 $4.1B +$378M +10.2% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $4.18B +$471M +12.7% Mar 31, 2020 10-Q 2020-04-29
Q4 2019 $4.26B +$532M +14.3% Dec 31, 2019 10-K 2021-02-18
Q3 2019 $3.91B +$342M +9.57% Sep 30, 2019 10-Q 2019-10-23
Q2 2019 $3.72B +$224M +6.4% Jun 30, 2019 10-Q 2019-07-24
Q1 2019 $3.71B +$249M +7.2% Mar 31, 2019 10-Q 2019-04-24
Q4 2018 $3.73B +$382M +11.4% Dec 31, 2018 10-K 2020-02-19
Q3 2018 $3.57B +$1.13B +46.3% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $3.5B +$1.14B +48.6% Jun 30, 2018 10-Q 2018-07-25
Q1 2018 $3.46B +$1.17B +51.3% Mar 31, 2018 10-Q 2018-04-25
Q4 2017 $3.34B +$1.1B +49.3% Dec 31, 2017 10-K 2019-02-20
Q3 2017 $2.44B +$286M +13.3% Sep 30, 2017 10-Q 2017-10-25
Q2 2017 $2.35B +$264M +12.6% Jun 30, 2017 10-Q 2017-07-26
Q1 2017 $2.29B +$209M +10.1% Mar 31, 2017 10-Q 2017-04-26
Q4 2016 $2.24B +$199M +9.77% Dec 31, 2016 10-K 2018-02-21
Q3 2016 $2.16B +$318M +17.3% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 $2.09B +$285M +15.8% Jun 30, 2016 10-Q 2016-07-27
Q1 2016 $2.08B +$360M +20.9% Mar 31, 2016 10-Q 2016-04-27
Q4 2015 $2.04B +$345M +20.4% Dec 31, 2015 10-K 2017-02-22
Q3 2015 $1.84B +$147M +8.66% Sep 30, 2015 10-Q 2015-10-28
Q2 2015 $1.8B +$125M +7.46% Jun 30, 2015 10-Q 2015-07-29
Q1 2015 $1.72B +$125M +7.82% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 $1.7B +$153M +9.94% Dec 31, 2014 10-K 2016-02-19
Q3 2014 $1.69B +$175M +11.5% Sep 30, 2014 10-Q 2014-10-29
Q2 2014 $1.68B +$168M +11.1% Jun 30, 2014 10-Q 2014-07-30
Q1 2014 $1.59B +$111M +7.52% Mar 31, 2014 10-Q 2014-04-30
Q4 2013 $1.54B +$155M +11.2% Dec 31, 2013 10-K 2015-02-24
Q3 2013 $1.52B +$281M +22.7% Sep 30, 2013 10-Q 2013-10-23
Q2 2013 $1.51B +$319M +26.8% Jun 30, 2013 10-Q 2013-07-24
Q1 2013 $1.48B +$441M +42.4% Mar 31, 2013 10-Q 2013-04-24
Q4 2012 $1.39B +$284M +25.8% Dec 31, 2012 10-K 2014-02-20
Q3 2012 $1.24B +$232M +23.1% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 $1.19B +$246M +26% Jun 30, 2012 10-Q 2012-07-25
Q1 2012 $1.04B +$130M +14.2% Mar 31, 2012 10-Q 2012-04-25
Q4 2011 $1.1B +$238M +27.5% Dec 31, 2011 10-K 2013-02-22
Q3 2011 $1B +$159M +18.8% Sep 30, 2011 10-Q 2011-10-26
Q2 2011 $946M +$123M +15% Jun 30, 2011 10-Q 2011-07-27
Q1 2011 $912M +$109M +13.6% Mar 31, 2011 10-Q 2011-04-27
Q4 2010 $865M Dec 31, 2010 10-K 2012-02-22
Q3 2010 $845M Sep 30, 2010 10-Q 2010-11-03
Q2 2010 $823M Jun 30, 2010 10-Q/A 2010-08-03
Q1 2010 $802M Mar 31, 2010 10-Q 2010-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.